139 related articles for article (PubMed ID: 9885234)
1. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity.
Semple JW; Speck ER; Cosgrave D; Lazarus AH; Blanchette VS; Freedman J
Blood; 1999 Jan; 93(2):713-20. PubMed ID: 9885234
[TBL] [Abstract][Full Text] [Related]
2. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation.
Semple JW; Speck ER; Milev YP; Blanchette V; Freedman J
Blood; 1995 Jul; 86(2):805-12. PubMed ID: 7606011
[TBL] [Abstract][Full Text] [Related]
3. Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens.
Bang KW; Speck ER; Blanchette VS; Freedman J; Semple JW
Blood; 2000 Mar; 95(5):1735-42. PubMed ID: 10688832
[TBL] [Abstract][Full Text] [Related]
4. IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells.
Sayeh E; Sterling K; Speck E; Freedman J; Semple JW
Blood; 2004 Apr; 103(7):2705-9. PubMed ID: 14656873
[TBL] [Abstract][Full Text] [Related]
5. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype.
Sayeh E; Aslam R; Speck ER; Le-Tien H; Lazarus AH; Freedman J; Semple JW
Transfusion; 2004 Nov; 44(11):1572-8. PubMed ID: 15504162
[TBL] [Abstract][Full Text] [Related]
6. Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase.
Bang A; Speck ER; Blanchette VS; Freedman J; Semple JW
Blood; 1996 Oct; 88(8):2959-66. PubMed ID: 8874192
[TBL] [Abstract][Full Text] [Related]
7. Role of class-II major histocompatibility complex (MHC)-antigen-positive donor leukocytes in transfusion-induced alloimmunization to donor class-I MHC antigens.
Kao KJ; del Rosario ML
Blood; 1998 Jul; 92(2):690-4. PubMed ID: 9657772
[TBL] [Abstract][Full Text] [Related]
8. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC
Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
[TBL] [Abstract][Full Text] [Related]
9. Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets.
Muench MO; Heitman JW; Inglis H; Fomin ME; Marschner S; Goodrich RP; Norris PJ; Jackman RP
Transfusion; 2016 Jun; 56(6):1419-29. PubMed ID: 27028210
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic platelet transfusions prevent murine T-cell-mediated immune thrombocytopenia.
Guo L; Yang L; Speck ER; Aslam R; Kim M; McKenzie CG; Lazarus AH; Ni H; Hou M; Freedman J; Semple JW
Blood; 2014 Jan; 123(3):422-7. PubMed ID: 24258817
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells.
Aslam R; Speck ER; Kim M; Freedman J; Semple JW
Transfusion; 2008 Sep; 48(9):1778-86. PubMed ID: 18522705
[TBL] [Abstract][Full Text] [Related]
12. Induction of humoral immune tolerance to major histocompatibility complex antigens by transfusions of UVB-irradiated leukocytes.
Kao KJ
Blood; 1996 Dec; 88(11):4375-82. PubMed ID: 8943875
[TBL] [Abstract][Full Text] [Related]
13. Effects of leukocyte depletion and UVB irradiation on alloantigenicity of major histocompatibility complex antigens in platelet concentrates: a comparative study.
Kao KJ
Blood; 1992 Dec; 80(11):2931-7. PubMed ID: 1450418
[TBL] [Abstract][Full Text] [Related]
14. CTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice.
Gilson CR; Patel SR; Zimring JC
Transfusion; 2012 Oct; 52(10):2209-19. PubMed ID: 22321003
[TBL] [Abstract][Full Text] [Related]
15. MHC II on transfused murine blood is not required for alloimmunization against MHC I.
Gilson CR; Cadwell CM; Smith NH; Hendrickson JE; Zimring JC
Vox Sang; 2010 Nov; 99(4):369-74. PubMed ID: 20546207
[TBL] [Abstract][Full Text] [Related]
16. Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice.
Couvidou A; Angénieux C; Ruch L; Mangin PH; Gachet C; Maître B
Blood Adv; 2023 Apr; 7(8):1356-1365. PubMed ID: 36490266
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions.
Waterman HR; Kapp LM; Munday A; Odem-Davis K; Zimring JC
Transfusion; 2016 Jan; 56(1):91-100. PubMed ID: 26400622
[TBL] [Abstract][Full Text] [Related]
18. Use of 8-methoxypsoralen and ultraviolet-A pretreated platelet concentrates to prevent alloimmunization against class I major histocompatibility antigens.
Grana NH; Kao KJ
Blood; 1991 Jun; 77(11):2530-7. PubMed ID: 1828180
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated inhibition of the human alloimmune response to platelet transfusion in Hu-PBL-SCID mice.
Crow AR; Freedman J; Hannach B; Blanchette V; Lazarus AH
Br J Haematol; 1999 Mar; 104(4):919-24. PubMed ID: 10192460
[TBL] [Abstract][Full Text] [Related]
20. Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model.
Gilson CR; Zimring JC
Transfusion; 2012 Apr; 52(4):849-59. PubMed ID: 21981241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]